N-methyl-D-aspartate receptor modulators and methods of making and using same
US9994614B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 24, 2015 |
| Grant date | Jun 12, 2018 |
| Priority date | — |
| Expiry date | Jul 24, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of diseases and disorders, such as learning, cognitive activities, and analgesia, particularly in alleviating and/or reducing neuropathic pain. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.